Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | SUITE 310, 3303 MONTE VILLA PARKWAY BOTHELL WA 98021 |
Tel: | 1-425-4021400 |
Website: | https://www.biolifesolutions.com |
IR: | See website |
Key People | ||
Roderick De Greef Chairman of the Board, Chief Executive Officer, President | Troy Wichterman Chief Financial Officer | Aby J. Mathew Executive Vice President, Chief Scientific Officer |
Geraint Phillips Senior Vice President - Global Operations | Todd Berard Chief Marketing Officer | Sarah Aebersold Vice President - Global Human Resources |
Karen A. Foster Chief Quality Officer | Garrie Richardson Chief Revenue Officer |
Business Overview |
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands. |
Financial Overview |
For the fiscal year ended 31 December 2023, BioLife Solutions Inc revenues decreased 11% to $143.3M. Net loss decreased 52% to $66.4M. Revenues reflect Product Revenue-Freezer and thaw segment decrease of 24% to $50.6M, Product Revenue-Cell processing segment decrease of 4% to $65.8M, United States segment decrease of 2% to $114.6M, Other Countries segment decrease of 11% to $5.7M. |
Employees: | 409 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $709.74M as of Dec 31, 2023 |
Annual revenue (TTM): | $143.27M as of Dec 31, 2023 |
EBITDA (TTM): | -$43.04M as of Dec 31, 2023 |
Net annual income (TTM): | -$66.43M as of Dec 31, 2023 |
Free cash flow (TTM): | -$23.74M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 45,300,000 as of Feb 22, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |